当前位置: X-MOL 学术Curr. Opin. Pharmacol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Treatment approach to connective tissue disease-associated interstitial lung disease
Current Opinion in Pharmacology ( IF 4 ) Pub Date : 2022-06-01 , DOI: 10.1016/j.coph.2022.102245
Timothy M Wilson 1 , Joshua J Solomon 2 , M Kristen Demoruelle 1
Affiliation  

Interstitial lung disease (ILD) is a common manifestation in connective tissue diseases (CTD), such as rheumatoid arthritis (RA), systemic sclerosis (SSc), and inflammatory myositis (IM). ILD is associated with significant morbidity and mortality in nearly all CTD highlighting the critical need for effective treatment strategies in this patient population. In this review, we will summarize the approach to treatment when there is concern for CTD-ILD and highlight recent advancements in therapeutics within various forms of CTD-ILD.



中文翻译:

结缔组织病相关间质性肺病的治疗方法

间质性肺病 (ILD) 是结缔组织病 (CTD) 的常见表现,如类风湿性关节炎 (RA)、系统性硬化症 (SSc) 和炎症性肌炎 (IM)。在几乎所有 CTD 中,ILD 与显着的发病率和死亡率相关,突出了对这一患者群体有效治疗策略的迫切需求。在这篇综述中,我们将总结关注 CTD-ILD 时的治疗方法,并重点介绍各种形式的 CTD-ILD 治疗的最新进展。

更新日期:2022-06-04
down
wechat
bug